Is this the CEO?
Rick Hawkins is the Chief Executive Officer, President, and Chairman of Lumos Pharma, Inc. Rick currently serves as Chairman of the Board of Directors for Plus Therapeutics, a NASDAQ-listed company. Rick is a member of the National Ernst & Young Entrepreneur of the Year Hall of Fame and was inducted into the Hall of Honor for the College of Natural Sciences at the University of Texas by Dean Mary Ann Rankin. In 2006, he received Ohio University's Distinguished Business Achievement Award, and in 2014, was awarded the Konneker Medal, the leading entrepreneurial honor awarded by the University. Rick was named one of the top 10 Life Sciences CEO's in Texas by the Texas Healthcare & Bioscience Institute and was the keynote speaker at BioVenture Showcase in 2008.
Mr. Hawkins currently serves as a Director for Plus Therapeutics (PSTV) and Savara Pharmaceuticals (SVRA).
Mr. Hawkins resides in Austin, Texas and maintains a residence near Columbus, Ohio.
Mr. Hawkins has served on the Lumos Pharma Board since 2012 and Chairman since March 2020.
Rick Hawkins is the Chief Executive Officer, President, and Chairman of Lumos Pharma, Inc. Rick currently serves as Chairman of the Board of Directors for Plus Therapeutics, a NASDAQ-listed company. Rick is a member of the National Ernst & Young Entrepreneur of the Year Hall of Fame and was inducted into the Hall of Honor for the College of Natural Sciences at the University of Texas by Dean Mary Ann Rankin. In 2006, he received Ohio University's Distinguished Business Achievement Award, and in 2014, was awarded the Konneker Medal, the leading entrepreneurial honor awarded by the University. Rick was named one of the top 10 Life Sciences CEO's in Texas by the Texas Healthcare & Bioscience Institute and was the keynote speaker at BioVenture Showcase in 2008.
Mr. Hawkins currently serves as a Director for Plus Therapeutics (PSTV) and Savara Pharmaceuticals (SVRA).
Mr. Hawkins resides in Austin, Texas and maintains a residence near Columbus, Ohio.
Mr. Hawkins has served on the Lumos Pharma Board since 2012 and Chairman since March 2020.
Recent PHCG News
- Mixie Technologies, Inc. (OTC: PHCG) Secures Minority Ownership Stake in Mixie Realty LLC • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- Mixie Technologies, Inc. (PHCG) Announces CES Picks Award Recognition for HoloTwin LLC • GlobeNewswire Inc. • 01/12/2026 01:50:00 PM
- Mixie Technologies, Inc. (PHCG), formerly Pure Harvest Corporate Group, Secures Minority Ownership Stake in HoloTwin LLC • GlobeNewswire Inc. • 01/07/2026 01:00:00 PM
- Mixie Technologies, Inc. (OTC: PHCG) formerly known as Pure Harvest Corporate Group, Executes Binding Letter of Intent to Acquire Minority Interest in HoloTwin LLC • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Pure Harvest Corporate Group (OTC: PHCG) Completes its Acquisition of Mixie IP Holdings and Mixie Labs • GlobeNewswire Inc. • 11/13/2025 01:30:00 PM
- This Quiet Micro-Cap Surges on AI and Immersive Tech Acquisition News • AllPennyStocks.com • 10/28/2025 03:20:00 PM
- Pure Harvest Corporate Group Signs Letter of Intent to Acquire Mixie IP Holdings and Mixie Labs • GlobeNewswire Inc. • 10/28/2025 12:30:00 PM
